Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head
PHASE2Not yet recruitingINTERVENTIONAL
Enrollment
170
Participants
Timeline
Start Date
April 30, 2024
Primary Completion Date
September 30, 2028
Study Completion Date
March 31, 2029
Conditions
Pancreatic Cancer Resectable
Interventions
DRUG
Acetylsalicylic acid
100 mg per os once daily
DRUG
Placebo
Placebo pill per os once daily
All Listed Sponsors
lead
German Cancer Research Center
OTHER
NCT05637567 - Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | Biotech Hunter | Biotech Hunter